Renovaro Biosciences Inc(NASDAQ:RENB) 
Renovaro Biosciences Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV...
Website: https://www.enochianbio.com/
Founded: 2011
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-02
P
O 5.20
H 5.40
L 4.90
C 5.20
V 636,156
10EMA 5.20
20EMA 5.20
60EMA 5.20
120EMA 5.20
250EMA 5.20